Along with these expansion plans, Elder pharma also prepares to explore the possibility of venturing into new therapeutic areas. As the firm expects an increase in its revenues, it aims at restructuring and restrategising its brands. While the company has already been seeing profits with its division of anti-infectives, the additional areas can prove to be more beneficial.
Now, Elder pharma aims at focusing on increasing its presence in the areas of injectables and anti-infectives to continue with the company’s growth. The company would additionally focus on creating a brand leadership in a particular segment by creating a product in a therapeutic category and develop its own portfolio. The other therapeutic areas that the company aims to concentrate on include neurological and cardio-vascular segments. -IGMPI
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…